As of November 6, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Precigen, Inc. The largest reported stake is Randal J. Kirk's, at 35.9%. 9 filings are on record since September 19, 2025 (Schedule 13D/A, March 31, 2026).
Sell to companies like Precigen, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Ares Trading SA · Sole voting: 17,467,152 · Shared voting: 0 · Sole dispositive: 17,467,152 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-07
- · Holder: Point72 Asset Management, L.P. · Percent: 1.9% · SCHEDULE 13G/A
- · Holder: Randal J. Kirk · Percent: 35.9% · SCHEDULE 13D/A
- · Holder: Patient Capital Management, LLC · Percent: 10.2% · SCHEDULE 13G/A
- · Holder: Point72 Asset Management, L.P. · Percent: 5.2% · SCHEDULE 13G
Precigen, Inc. has 9 Schedule 13D or 13G filings on record since 2025-09-19. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 35.9% | 133,956,416 | SCHEDULE 13D/A, 2026-03-31 | 2026-03-30 | |
| Patient Capital Management, LLC | 10.2% | 36,006,800 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| William H. Miller III Living Trust dated April 17, 2017 | 9.2% | 34,051,925 | SCHEDULE 13G, 2025-09-23 | 2025-06-26 |
| Ares Trading SA | 4.9% | 17,467,152 | SCHEDULE 13G/A, 2026-08-07 | 2026-06-09 |
| Point72 Asset Management, L.P. | 1.9% | 6,741,861 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
Holding shares or following this stake? See who's behind Precigen, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Precigen, Inc. and the records around it.
Precigen, Inc. elsewhere on the record
Companies that share a holder
- Patient Capital Management, LLC also filed stake reports on 2 other companies: Dave & Buster's Entertainment, Inc. (May 2026), Canada Goose Holdings Inc. (Aug 2025)
- Point72 Asset Management, L.P. also filed stake reports on 90 other companies: Immunocore Holdings plc (Nov 2026), Target Hospitality Corp. (Nov 2026), E.W. SCRIPPS Co (Oct 2026)
Watch Precigen, Inc.
Get an email when Precigen, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Precigen, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Precigen, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Precigen, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Ares Trading SA | 17,467,152 | 0 | 17,467,152 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Merck Serono SA, Aubonne, Switzerland, an affiliate of Merck KGaA, Darmstadt | 17,467,152 | 0 | 17,467,152 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| Merck KGaA, Darmstadt, Germany | 17,467,152 | 0 | 17,467,152 | 0 | SCHEDULE 13G/A, 2026-08-07 |
| E. Merck KG, Darmstadt Germany | 17,467,152 | 0 | 17,467,152 | 0 | SCHEDULE 13G/A, 2026-08-07 |
The latest filing identifies Precigen, Inc. by CUSIP 46122T102 and gives its principal executive office as 20374 Seneca Meadows Parkway, Germantown, MD 20876 (SCHEDULE 13G/A, 2026-08-07).
Purpose of Transaction (Item 4)
Randal J. Kirk
Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: The information set forth in Items 3 and 6 is incorporated herein by reference. The Selling Entities sold a total of 4,772,781 shares of Common Stock in open market transactions on March 30, 2026, for aggregate net proceeds of approximately $15,581,221.Item 4 of the SCHEDULE 13D/A filed 2026-03-31
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-09-19 | Randal J. Kirk | 39.4% | SCHEDULE 13D/A |
| 2025-09-23 | William H. Miller III Living Trust dated April 17, 2017 | 9.2% | SCHEDULE 13G |
| 2025-10-30 | Patient Capital Management, LLC | 13.6% | SCHEDULE 13G/A |
| 2025-11-21 | Randal J. Kirk | 38.1% | SCHEDULE 13D/A |
| 2026-01-23 | Point72 Asset Management, L.P. | 5.2% | SCHEDULE 13G |
| 2026-02-13 | Patient Capital Management, LLC | 10.2% | SCHEDULE 13G/A |
| 2026-03-31 | Randal J. Kirk | 35.9% | SCHEDULE 13D/A |
| 2026-05-15 | Point72 Asset Management, L.P. | 1.9% | SCHEDULE 13G/A |
| 2026-08-07 | Ares Trading SA | 4.9% | SCHEDULE 13G/A |
Questions about who owns Precigen, Inc.
Who owns Precigen, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Precigen, Inc.: Randal J. Kirk (35.9%, Schedule 13D/A, filed 2026-03-31), Patient Capital Management, LLC (10.2%, Schedule 13G/A, filed 2026-02-13) and William H. Miller III Living Trust dated April 17, 2017 (9.2%, Schedule 13G, filed 2025-09-23).
Who are the largest shareholders of Precigen, Inc.?
By the share each holder's latest filing reports, the largest holders of Precigen, Inc. on this page are Randal J. Kirk (35.9%), Patient Capital Management, LLC (10.2%) and William H. Miller III Living Trust dated April 17, 2017 (9.2%).
When did Randal J. Kirk buy into Precigen, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Randal J. Kirk on this page is the Schedule 13D/A, filed 2025-09-19, reporting 39.4%; its latest, Schedule 13D/A filed 2026-03-31, reports 35.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Precigen, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.